Geodesic
NMR spectroscopy, metabonomics and biopharmaceutics
Učënye zapiski Kazanskogo universiteta. Seriâ Fiziko-matematičeskie nauki, Uchenye Zapiski Kazanskogo Universiteta. Seriya Fiziko-Matematicheskie Nauki, Tome 154 (2012) no. 1, pp. 33-44 Cet article a éte moissonné depuis la source Math-Net.Ru

Voir la notice du chapitre de livre

The main fields of application of NMR spectroscopy for studying metabonomic profiles of biological fluids are analyzed. Comparative characteristics of various methods for metabonomic investigation of the structure of biological fluids from the point of view of sensitivity and selectivity are given. It is shown that NMR spectroscopy can be effectively used in pharmaceutics to identify the authenticity of drugs and when searching for impurities.
Keywords: NMR, metabonomics, pharmaceutics. 
@article{UZKU_2012_154_1_a2,
     author = {N. M. Sergeyev and K. F. Sheberstov and V. N. Torocheshnikov and N. D. Sergeyeva},
     title = {NMR spectroscopy, metabonomics and biopharmaceutics},
     journal = {U\v{c}\"enye zapiski Kazanskogo universiteta. Seri\^a Fiziko-matemati\v{c}eskie nauki},
     pages = {33--44},
     year = {2012},
     volume = {154},
     number = {1},
     language = {ru},
     url = {http://geodesic.mathdoc.fr/item/UZKU_2012_154_1_a2/}
}
TY  - JOUR
AU  - N. M. Sergeyev
AU  - K. F. Sheberstov
AU  - V. N. Torocheshnikov
AU  - N. D. Sergeyeva
TI  - NMR spectroscopy, metabonomics and biopharmaceutics
JO  - Učënye zapiski Kazanskogo universiteta. Seriâ Fiziko-matematičeskie nauki
PY  - 2012
SP  - 33
EP  - 44
VL  - 154
IS  - 1
UR  - http://geodesic.mathdoc.fr/item/UZKU_2012_154_1_a2/
LA  - ru
ID  - UZKU_2012_154_1_a2
ER  - 
%0 Journal Article
%A N. M. Sergeyev
%A K. F. Sheberstov
%A V. N. Torocheshnikov
%A N. D. Sergeyeva
%T NMR spectroscopy, metabonomics and biopharmaceutics
%J Učënye zapiski Kazanskogo universiteta. Seriâ Fiziko-matematičeskie nauki
%D 2012
%P 33-44
%V 154
%N 1
%U http://geodesic.mathdoc.fr/item/UZKU_2012_154_1_a2/
%G ru
%F UZKU_2012_154_1_a2
N. M. Sergeyev; K. F. Sheberstov; V. N. Torocheshnikov; N. D. Sergeyeva. NMR spectroscopy, metabonomics and biopharmaceutics. Učënye zapiski Kazanskogo universiteta. Seriâ Fiziko-matematičeskie nauki, Uchenye Zapiski Kazanskogo Universiteta. Seriya Fiziko-Matematicheskie Nauki, Tome 154 (2012) no. 1, pp. 33-44. http://geodesic.mathdoc.fr/item/UZKU_2012_154_1_a2/

[1] J. C. Lindon, J. K. Nicholson, E. Holmes (eds.), The handbook of metabonomics and metabolomics, Elsevier, 2007, 572 pp.

[2] W. Weckwerth (ed.), Metabolomics: methods and protocols, Humana Press Inc., 2007, 312 pp.

[3] Holmes E., Wilson I. D., Nicholson J. K., “Metabolic phenotyping in health and disease”, Cell, 134:5 (2008), 714–717 | DOI

[4] Coen M., Holmes E., Lindon J. C., Nicholson J. K., “NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology”, Chem. Res. Toxicol., 21:1 (2008), 9–27 | DOI

[5] Beckwith-Hall B. M., Nicholson J. K., Nicholls A. W., Foxall P. J., Lindon J. C., Connor S. C., Abdi M., Connelly J., Holmes E., “Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins”, Chem. Res. Toxicol., 11:4 (1998), 260–272 | DOI

[6] Griffin J., “The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball?”, Philos. Trans. R. Soc. Lond. B Biol. Sci., 361:1465 (2006), 147–161 | DOI

[7] Kim H. K., Wilson E. G., Choi Y. H., Verpoorte R., “Metabolomics: a tool for anticancer lead-finding from natural products”, Planta. Med., 76:11 (2010), 1094–1102 | DOI

[8] Ala-Korpela M., “Potential role of body fluid $^1$H NMR metabonomics as a prognostic and diagnostic tool”, Expert Rev. Mol. Diagn., 7:6 (2007), 761–773 | DOI

[9] Duarte I. F., Marques J., Ladeirinha A. F., Rocha C., Lamego I., Calheiros R., Silva T. M., Marques M. P., Melo J. B., Carreira I. M., Gil A. M., “Analytical approaches toward successful human cell metabolome studies by NMR spectroscopy”, Anal. Chem., 81:12 (2009), 5023–5032 | DOI

[10] Serkova N. J., Spratlin J. L., Eckhardt S. G., “NMR-based metabolomics: translational application and treatment of cancer”, Curr. Opin. Mol. Ther., 9:6 (2007), 572–585

[11] Nikolsky Yu., Nikolskaya T., Bugrim A., “Biological networks and analysis of experimental data in drug discovery”, Drug Discov. Today, 10:9 (2005), 653–662 | DOI

[12] Seli E., Botros L., Sakkas D., Burns D. H., “Noninvasive metabolomic profiling of embryo culture media using proton nuclear magnetic resonance correlates with reproductive potential of embryos in women undergoing in vitro fertilization”, Fertil. Steril., 90:6 (2008), 2183–2189 | DOI

[13] Goodacre R., “Metabolomics – the way forward”, Metabolomics, 1:1 (2005), 1–2 | DOI

[14] Spraul M., Schütz B., Humpfer E., Mörtter M., Schäfer H., Koswig S., Rinke P., “Mixture analysis by NMR as applied to fruit juice quality control”, Magn. Reson. Chem., 47, Suppl. 1 (2009), S130–S137 | DOI

[15] Golotvin S., Williams A., “Improved baseline recognition and modeling of FT NMR spectra”, J. Magn. Res., 146:1 (2000), 122–125 | DOI

[16] Kolokolova T. N., Savelev O. Yu., Sergeev N. M., “Metabolicheskii analiz biologicheskikh zhidkostei cheloveka na osnove spektroskopii YaMR $^1$N”, Zhurn. anal. khimii, 63:2 (2008), 118–136

[17] Kolokolova T. N., Savelev O. Yu., Sergeev N. M., Shpigun O. A., Sokolov K. V., Skvortsova V. I., “Spektroskopiya yadernogo magnitnogo rezonansa v reshenii analiticheskikh zadach meditsiny. Analiz tserebrospinalnoi zhidkosti”, Zhurn. anal. khimii, 65:10 (2010), 1096–1105

[18] Kutyshenko V. P., Sviridova-Chailakhyan T. A., Molochkov N. V., Chailakhyan L. M., “Issledovanie metodom YaMR vysokogo razresheniya sostava organicheskikh soedinenii reproduktivnykh organov samtsov myshei”, Dokl. RAN, 420:1 (2008), 124–129

[19] Kutyshenko V. P., Sviridova-Chailakhyan T. A., Stepanov A. A., Chailakhyan L. M., “Issledovanie sostava organicheskikh soedinenii v rannikh zarodyshakh myshei metodom protonnogo magnitnogo rezonansa”, Dokl. RAN, 422:3 (2008), 405–409

[20] Counterfeit Drugs. Guidelines for the development of measures to combat counterfeit drugs, URL: , Department of Essential Drugs and Other Medicines, World Health Organization, Geneva, Switzerland, 1999, 62 pp. http://whqlibdoc.who.int/hq/1999/WHO_EDM_QSM_99.1.pdf

[21] Trefi S., Gilard V., Balayssac S., Malet-Martino M., Martino R., “The usefulness of 2D DOSY and 3D DOSY-COSY 1H NMR for mixture analysis: application to genuine and fake formulations of sildenafil (Viagra)”, Magn. Reson. Chem., 47, Suppl. 1 (2009), S163–S173 | DOI

[22] Holzgrabe U., “Quantitative NMR spectroscopy in pharmaceutical applications”, Prog. Nucl. Magn. Reson. Spectrosc., 57:2 (2010), 229–240 | DOI

[23] Beyer T., Diehl B., Randel G., Humpfer E., Schafer H., Spraul M., Schollmayer C., Holzgrabe U., “Quality assessment of unfractionated heparin using $^1$H nuclear magnetic resonance spectroscopy”, J. Pharm. Biomed. Anal., 48:1 (2008), 13–19 | DOI

[24] Robertson D. G., Reily M. D., Sigler R. E., Wells D. F., Paterson D. A., Braden T. K., “Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants”, Toxicol. Sci., 57:2 (2000), 326–337 | DOI

[25] Schaber G., Wiatr G., Wachsmuth H., Dachtler M., Albert K., Gaertner I., Breyer-Praf U., “Isolation and identification of clozapine metabolites in patient urine”, Drug Metab. Dispos., 29:6 (2001), 923–931

[26] Peng S. X., “Hyphenated HPLC-NMR and its applications in drug discovery”, Biomed. Chromatogr., 14:6 (2000), 430–441 | 3.0.CO;2-P class='badge bg-secondary rounded-pill ref-badge extid-badge'>DOI

[27] Quinones M. P., Kaddurah-Daouk R., “Metabolomics tools for identifying biomarkers for neuropsychiatric diseases”, Neurobiol. Dis., 35:2 (2009), 165–176 | DOI

[28] Lacey M. E., Subramanian R., Olson D. L., Webb A. G., Sweedler J. V., “High-resolution NMR spectroscopy of sample volumes from 1 nL to 10 $\mu$L”, Chem. Rev., 99:10 (1999), 3133–3152 | DOI